Dopamine-Derived Biological Reactive Intermediates and Protein Modifications: Implications for Parkinson's Disease

Chemico-Biological Interactions - Ireland
doi 10.1016/j.cbi.2011.01.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dopamine Transporter Imaging Assessment of Parkinson's Disease Progression

2000English

Constrictive Pericarditis and Pleuropulmonary Disease Linked to Ergot Dopamine Agonist Therapy (Cabergoline) for Parkinson's Disease

Mayo Clinic Proceedings
Medicine
1999English

Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease

Journal of Neuroscience
Neuroscience
2011English

Molecular Characterization of Dopamine-Derived Quinones Reactivity Toward NADH and Glutathione: Implications for Mitochondrial Dysfunction in Parkinson Disease

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2010English

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine

Movement Disorders Clinical Practice
Neurology
2019English

Biological Roles of Protein Hyperstability: Implications for Biotechnology

Biophysical Journal
Biophysics
2017English

Rationale for Use of Dopamine Agonists in Parkinson's Disease: Review of Ergot Derivatives

Canadian Journal of Neurological Sciences
MedicineNeurology
1999English

Goal-Directed and Habitual Control in the Basal Ganglia: Implications for Parkinson's Disease

Nature Reviews Neuroscience
Neuroscience
2010English

Glutathione Depletion in Immortalized Midbrain-Derived Dopaminergic Neurons Results in Increases in the Labile Iron Pool: Implications for Parkinson's Disease

Free Radical Biology and Medicine
BiochemistryPhysiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy